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play substantial improvement over alternatives, as shown below. Approximately 50 rare
cardiac structures including Fontan and atypical aortic anatomies have been recon-
structed.
Conclusions
Benefits of our technique are particularly evident when complex vascular configurations
complicate reconstruction. Our methodology creates a powerful tool allowing physicians
to analyze and manipulate vascular structures interactively. This technology enables the
execution of virtual operations with which surgeons can create and evaluate potential
post-operative anatomies.
4:30 p.m.
854-3 Fundamental Errors in Current Applications of Gorlin 
Formula and Continuity Equation for Aortic Valve 
Anatomical Orifice Area Estimate
Karl Isaaz, Sylvie Schouvey, University of Saint Etienne, Saint Etienne, France
Hypothesis. Aortic stenosis (AS) valve orifice area (AVA) can be calculated either from
flow rates and pressure gradients (PG) by the Gorlin formula (AVAg = flow rate/K.PG^0.5)
or from subvalvular and transvalvular velocities (Vsub,Vtv) by the continuity equation
(AVAc = LVoutflow tract area .Vsub/Vtv). In current practice, mean values for flow rates,
PG and velocities are used in both formula to derive mean AVA. However, as flow is pul-
satile, mean AVA should mathematically be calculated by time averaging of instanta-
neous values for AVAg or AVAc. We hypothesized that such fundamental errors may
significantly alter the estimate of actual mean AVA. Methods. A computer model of AS
with AVA variability during ejection (T) was developed. Vtv, pressure recovery (PR), PG
and PGnet (PG-PR) were computerized based on hydrodynamic equations. Mean AVA
was estimated from mean AVAc and 8 Gorlin formula : g1= mean flow rate/
44.3meanPG^0.5, g2 = mean flow rate/50meanPG^0.5, g3 = mean flow rate/
44.3PGnet^0.5, g4= mean flow rate/50PGnet^0.5, g5 = 1/T int[flow rate(t)/
44.3PG(t)^0.5.dt], g6 =1/T int[flow rate(t)/50PG(t)^0.5.dt], g7 =1/T int [flow rate(t)/
44.3PGnet(t)^0.5.dt ] and g8 = 1/T int [flow rate(t)/50PGnet(t)^0.5.dt]. Results : Table.
Conclusion: Significant errors in mean AVA estimate result from Gorlin and continuity
equations when mean values for flow, pressure gradients and velocities are used, Gorlin
formula based on time averaging of instantaneous values for AVAg with K = 50 provides
the best results
4:45 p.m.
854-4 Clinical Application of Eigenvalue Analysis and the 
Derived Electrocardiogram as a Real-Time Marker for 
Infarction
David M. Schreck, Atul Prakash, Cristian Brotea, Sumit Shah, Jeffrey Sparrow, Capital 
Health System, Trenton, NJ, Atlantic Health System, Summit, NJ
Background: The electrocardiogram (ECG) may be described as a lead-vector array and
may be derived from 3 standard leads using a simplex optimization (SO) transformation
matrix. Each ECG array has associated eigenvalues (EV) that can be identified by Factor
Analysis (FA) to quantify the ECG information space.
Objective: To calculate the EVs of normal and infarction, measured and derived 12-lead
standard ECGs, and to determine whether the EVs can distinguish acute ECG pathology
using this computer-aided diagnostic technique.
Methods: Thirty-four standard 12-lead ECGs, including 22 normal and 12 with acute
myocardial infarction (AMI), were acquired and digitized yielding 300 voltage-time points
for each of the 8 measured ECG leads. Each of the 34 measured ECGs was also derived
from leads I, aVF, and V2 using a SO transformation matrix. EVs for each measured and
derived 300 x 8 voltage-time array were calculated using FA.ANOVA was used to test for
the statistical significance of the contribution of each EV% to the information content in
each patient array.
Results: FA of the 34 measured ECGs confirmed that 3 leads account for 99.2% ± 0.22%
of the information content in the 12-lead ECG set of test cases. No diagnostic morpho-
logic differences between measured and derived ECGs were noted. Significant differ-
ences (p < 0.05) between AMI and normal measured ECGs were detected at EV3%,
EV4%, EV5%, EV6%, and EV7%. Significant differences were also detected at EV3% for
derived ECGs (EV4-EV8 are null by definition in a 3 lead model for the derived 12-lead
ECGs). The sum of EV3% through EV8% were plotted and demonstrated complete dif-
ferentiation of normal ECGs from infarction ECGs in all 34 cases for both measured and
derived ECGs.
Conclusions: This study showed that the EVs in a standard ECG may differentiate normal
from AMI pathology. This computer-aided diagnostic calculation is performed instanta-
neously in real-time to enhance emergency care and patient observation capabilities.
The 12-lead ECG can be derived from a SO transformation matrix using only 3 measured
leads from which the EVs can be calculated. We propose that the ECG eigenvalues are a
new marker for real-time continuous prediction of AMI.
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889-1 A Randomized Controlled Trial of Internet-Based 
Academic Detailing in Heart Failure: Failure to Engage 
or Change
Nancy M. Allen LaPointe, Judith M. Kramer, Elizabeth R. DeLong, Lawrence H. 
Muhlbaier, Anita Chen, Bradley G. Hammill, Charles B. McCants, Robert M. Califf, Duke 
Clinical Research Institute, Durham, NC
Background: Despite a survival benefit and guideline recommendation for beta-blockers
(BB) in heart failure (HF), BB are underused in clinical practice.
Methods: In year 2000, patients with EF < 40% or a clinical diagnosis of HF were identi-
fied in the Duke Databank for Cardiovascular Disease (DDCD) and grouped by the refer-
ring medical practice. Practices with > 15 patients in DDCD were identified for a
prospective, randomized study using a multifaceted intervention to improve BB use in HF
patients. All physicians in each practice were asked to participate; however, practices
were randomized if at least one physician in the practice agreed to participate. Interven-
tion practices received provider education using an interactive, Internet-based program
with thought leaders; patient education materials; feedback on their HF patients’ BB use;
and access to HF experts via telephone. The primary outcome was a comparison
between intervention and control practices of the proportion of HF patients self-reporting
BB use on their first routine DDCD follow-up in the post-intervention year. A random
effects model was used for the analysis.
Results: Sixty-six of 319 physicians (21%) agreed to participate, representing 45 of 66
medical practices (68%) in 3 states. Twenty-two practices were randomized to control
and 23 to intervention. Only 11 of 120 (9%) eligible physicians representing 9 interven-
tion practices accessed the Internet program. Post-intervention, 2,631 patients (1,701 in
intervention practices and 930 in control practices) completed DDCD follow-up. There
was no significant difference in the proportion of patients self-reporting BB use between
intervention and control practices (46% vs 47%, respectively). Conclusion: Extension of
the concept of academic detailing using the Internet in a multifaceted intervention was
not successful in either soliciting participation or changing practice in the outpatient set-
ting. The development of new economic or quality incentives in the ambulatory setting is
needed to influence prescribing in outpatients.
10:45 a.m.
889-2 Activating Patients: Drivers of Self-Efficacy in Heart 
Failure
Mark W. Conard, C. Keith Haddock, WS Carlos Poston, Saif Rathore, Harlan M. 
Krumholz, John A. Spertus, Megan Pinkston, Mid America Heart Institute/St. Luke's 
Hospital, Kansas City, MO
Background: The cornerstone of modern heart failure (HF) care is the engagement of
patients in managing their disease. Understanding patient factors associated with less
confidence in self-management can identify opportunities to tailor educational materials
to those who most need them. We examined a range of demographic, clinical and health
status characteristics associated with patients' sense of Self-efficacy.
Methods: 547 HF patients (EF<40%) were enrolled from 13 North American centers in
an observational study assessing their health status. Self-efficacy was quantified with the
Kansas City Cardiomyopathy Questionnaire (KCCQ), in which patients are asked
whether they know what to do to prevent their HF from getting worse or whom to call if
their HF worsens. Scores range from 0-100 where higher scores reflect greater confi-
dence in self-management. Potential predictive characteristics for patients' self-efficacy
were age, race (black vs. white), marital status, gender, education level (college graduate
vs. not), ejection fraction, NYHA class, body mass index, number of medications, self-
reported difficulty taking medications (not difficult vs. somewhat-to-extremely difficult),
income and vital signs.
Results: In multivariate models, independent predictors of Self-efficacy were race
(+6.1±1.9 points, p=0.002), gender (-3.9±2 for men, p=0.047), educational level
(+4.3±2.1 for college graduates, p=0.04), NYHA class (-3.3±1.1 per class, p=0.004), age
(-0.2±0.06 points/year, p=0.01) and difficulty taking medications (-12.8±2.4, p<0.001).
The model accounted for 11.2% of the variance in Self-efficacy scores.
Conclusions: Patients most likely to have a poor sense of Self-efficacy were older,
For mean AVA = 0.70cm^2
AVAc AVAg1 AVAg2 AVAg3 AVAg4 AVAg5 AVAg6 AVAg7 AVAg8
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black, less educated, having difficulty taking their medications, female and with more
advance NYHA class. Screening such HF patients and providing greater education may
enhance their ability to participate in actively managing their HF.
11:00 a.m.
889-3 Estimating Life-Years Lost Due to Atherothrombotic 
Events: Flexible Survival Functions for Use in Disease 
Modeling
J. Jaime Caro, Kristen Migliaccio-Walle, K. Jack Ishak, William S. Weintraub, Caro 
Research Institute, Concord, MA, Emory University, Atlanta, GA
Background: The cost-effectiveness of new interventions is of growing importance.
Researchers must now translate trial findings to costs per life year gained to enable com-
parability, making proper estimation of survival after a morbid event an essential task.
This analysis must account for the patterns of events observed in the trial.
Methods: Records of all acute myocardial infarctions (MI) occurring in Saskatchewan
during the years 1990-1995 were obtained. Patient characteristics and medical history
were available from January 1980; follow-up was complete to December 2000. Functions
were fit to observed, time-dependent, mortality hazards for: all patients, acutely non-fatal
atherothrombotic event, or no subsequent event. The resulting survival curves were inte-
grated to obtain the mean survival; life years lost due to additional events were derived by
subtracting the pattern-specific life expectancy from that of no events.
Results: Over the mean 5.1 years of follow-up, 49% of the 15,590 patients (64% male;
mean age 69 years; 24% diabetic; 30% previous MI or stroke; 61% hypertensive) died. In
the first 9 months, 5% suffered a non-fatal MI, 1% a non-fatal stroke, and 72% had no
non-fatal events. The hazard functions indicate high risk of death immediately following
the index MI, but risks drop sharply as time passes without an event. Subsequent events
lead to renewed risk. The integrated survival curves reveal the impact of additional
events. For example, a 65 year-old man has a life expectancy of 9.6 years immediately
after an MI. This increases to 10.8 years if he survives the first week and to 11.7 years if
he survives through 9 months with no further events; 4.4 years are lost if a second MI
occurs, 7.2 years with a stroke.
Conclusion: These techniques yielding detailed survival functions enable researchers to
avoid the inaccuracies introduced by using average, unadjusted, life expectancies from
non-specific populations. They allow extensive customization to obtain life-years lost for
any pattern of events in any given population. A second MI or a stroke is associated with
a continuing increased hazard of death, even if not immediately fatal, and must be con-
sidered in economic analyses.
11:15 a.m.
889-4 Cost-Effectiveness of Carvedilol Versus Metoprolol 
Tartrate for Patients With Heart Failure
Paul A. Heidenreich, VA Palo Alto Health Care System, Palo Alto, CA, Stanford 
University, Stanford, CA
The Carvedilol or Metoprolol European Trial in Patients With Chronic Heart Failure
(COMET) observed a mortality benefit for carvedilol over metoprolol tartrate. However,
the cost-effectiveness of carvedilol is unclear.
Methods: We used a Markov model to simulate lifetime outcome and cost of care using
COMET data. The age of the cohort was 62 years and 80% were male. Carvedilol
improved survival (hazard ratio for death 0.87) but was assumed to increase drug cost by
$1,062 per year. Per COMET, we assumed no difference in hospitalizations. The model
used societal perspective, costs adjusted to 2002 dollars, and a discount rate of 3%. Sur-
vival was calculated as both life years and quality adjusted life years (QALYs) using a
time-tradeoff utility of 0.71 for symptomatic heart failure.
Results: Carvedilol treatment increased the lifetime discounted cost of care by $10,330
and discounted survival by 0.73 years, (0.52 QALYs). The incremental cost-effectiveness
of carvedilol was $14,240 per life-year gained ($20,050 per QALY gained). Carvedilol
remained economically attractive even if the benefit did not persist following the end of
the trial (5 years, Figure). If the benefit of carvedilol in women is as reported by COMET
(hazard ratio 0.97) then carvedilol is less economically attractive ($66,830 per life year
gained, $93,80 per QALY gained).
Conclusion: Compared to metoprolol tartrate, carvedilol improves outcome for heart fail-
ure patients at a cost that is less than other commonly accepted medical treatments. 
11:30 a.m.
889-5 Looking Proximally to Understand Distal Outcomes: 
Gender Differences in Mortality After Acute Myocardial 
Infarction
Padma Kaul, Cynthia M. Westerhout, Wei-ching Chang, Paul W. Armstrong, University of 
Alberta, Edmonton, AB, Canada
Background: Conventional population studies examining possible gender bias in pro-
cess of care and outcomes of acute myocardial infarction (AMI) have been restricted to
the inpatient setting. To be comprehensive, these evaluations should ideally incorporate
more proximal care, i.e., at presentation to the emergency department (ED).
Methods: Between April 1998 and March 2000, 5309 (3622 Males; 1687 Females) resi-
dents of Alberta, Canada presented to hospital EDs with a primary diagnosis of AMI
(ICD-9-CM 410.xx).
Results: AMI patients (pts) who died in the ED (n=213) or who were not admitted
(n=406) accounted for 12% of the population and 29% of 1-year deaths (Figure). One-
year cardiovascular (re) admission rates were 48% among the AMI cohort initially admit-
ted and 30% among those discharged from the ED (p<0.01). Among AMI pts who did not
die in the ED, women were older (median age 72 y vs. 63 y among males, p<0.01); were
more likely to be discharged (9.5% vs. 7.3%, p<0.01); received fewer cardiac procedures
by 1-year; and had higher 1-year mortality (18.1% vs. 11.7% p<0.01). However, the dif-
ference in mortality disappeared after accounting for age (p=0.89)
Conclusion: Our examination at a more proximal point of care (ED) identifies a key high-
risk segment of the population accounting for 29% of AMI deaths. Future analyses
should therefore incorporate pts who died in the ED and those who were discharged. The
finding of higher rate of discharge of women with AMI from the ED is intriguing and
deserves further exploration.
11:45 a.m.
889-6 A Simple Model Using the MUSTT Database Can Stratify 
Total Mortality and Sudden Death Risk of Coronary 
Disease Patients
Alfred E. Buxton, Kerry L. Lee, Gail E. Hafley, Eric N. Prystowsky, Mark E. Josephson, 
John D. Fisher, Michael R. Gold, The MUSTT Investigators, Brown Medical School, 
Providence, RI, Duke Clinical Research Center, Durham, NC
Background:Many factors besides ejection fraction (EF) impact on prognosis of patients
(pts) with coronary disease (CAD). We reasoned that consideration of multiple parame-
ters should enable more precise risk stratification of CAD pts considered for defibrillator
(ICD) implantation for primary prevention of sudden death.
Methods: Using a Cox model we found 24 noninvasive and invasive parameters that influ-
enced total mortality (TM) and arrhythmic death or cardiac arrest (AD/CA) in all 1791
patients enrolled in the Multicenter Unsustained Tachycardia Trial (MUSTT) who did not
receive antiarrhythmic therapy. Five factors had the greatest impact on events: digitalis
use at time of enrollment, discovery of nonsustained ventricular tachycardia (NSVT) >10
days after bypass surgery (CABG), EF <=30%, Age >=65 years, presence of IVCD or
